Skip to main content
. 2020 Feb 12;10:93. doi: 10.3389/fonc.2020.00093

Figure 5.

Figure 5

Forest plots of the sensitivity and specificity of DCE-MRI for evaluation of the pathological response of breast cancer to neoadjuvant chemotherapy. I2 > 50% indicated substantial heterogeneity in the diagnostic parameters across studies.